These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8592404

  • 1. The mechanism of UVB prevention of graft versus host disease.
    Greenfeld JI, Chabot JA, Oluwole SF, Hardy MA.
    J Surg Res; 1996 Jan; 60(1):137-41. PubMed ID: 8592404
    [Abstract] [Full Text] [Related]

  • 2. Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation.
    Gowing H, Braakman E, Hagenbeek A, Lawler M, McCann SR, Pamphilon DH, Martens AC.
    Bone Marrow Transplant; 1998 Apr; 21(8):801-7. PubMed ID: 9603404
    [Abstract] [Full Text] [Related]

  • 3. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
    Ohajekwe OA, James T, Hardy MA, Oluwole SF.
    Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
    [Abstract] [Full Text] [Related]

  • 4. Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease.
    Gorantla VS, Prabhune KA, Perez-Abadia G, Ildstad ST, Maldonado C, Orhun HI, Majzoub RK, Francois CG, Kakoulidis TP, Brouha PC, Anderson GL, Pidwell DJ, Breidenbach WC, Barker JH.
    Transplantation; 2003 Apr 15; 75(7):922-32. PubMed ID: 12698075
    [Abstract] [Full Text] [Related]

  • 5. Prevention of graft-versus-host disease and bone marrow rejection: kinetics of induction of tolerance by UVB modulation of accessory cells and T cells in the bone marrow inoculum.
    Oluwole SF, Engelstad K, James T.
    Blood; 1993 Mar 15; 81(6):1658-65. PubMed ID: 8453111
    [Abstract] [Full Text] [Related]

  • 6. UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents.
    Yaron I, Yaron R, Oluwole SF, Hardy MA.
    Cell Immunol; 1996 Mar 15; 168(2):258-66. PubMed ID: 8640873
    [Abstract] [Full Text] [Related]

  • 7. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR, Majewski D, Hanson G.
    Biol Blood Marrow Transplant; 1999 Mar 15; 5(4):222-30. PubMed ID: 10465102
    [Abstract] [Full Text] [Related]

  • 8. UVB-irradiation of human bone marrow: potential for donor specific tolerance.
    Noizat-Pirenne F, Greenfeld JI, Hardy MA, Oluwole SF, De Groote D, Franchimont P.
    J Surg Res; 1996 Feb 15; 61(1):267-74. PubMed ID: 8769977
    [Abstract] [Full Text] [Related]

  • 9. UV-B modulation of haplo-identical bone marrow cells in the prevention of GVHD and induction of specific transplantation tolerance to intestinal allografts.
    Chowdhury NC, Jin MX, Hardy MA, Oluwole SF.
    Transpl Immunol; 1994 Dec 15; 2(4):331-6. PubMed ID: 7704543
    [Abstract] [Full Text] [Related]

  • 10. Effects of ultraviolet-B irradiation on human LAK and NK cytotoxic activity.
    Yaron I, Zakheim AR, Oluwole SF, Hardy MA.
    Cell Immunol; 1995 Oct 15; 165(2):168-76. PubMed ID: 7553880
    [Abstract] [Full Text] [Related]

  • 11. Graft versus host disease in rats made tolerant for organ allografts.
    Morrissey NJ, Blom D, Ryan C, Fisher T, Bronsther O, Orloff M.
    J Surg Res; 1997 May 15; 69(2):307-15. PubMed ID: 9224398
    [Abstract] [Full Text] [Related]

  • 12. UVB irradiated allogeneic bone marrow transplantation in rats: prevention of graft versus host disease without immunosuppression.
    Pepino P, Hardy MA, Chabot JA, Berger C, Marboe C, Wasfie T.
    Transplant Proc; 1989 Feb 15; 21(1 Pt 3):2995-6. PubMed ID: 2523168
    [No Abstract] [Full Text] [Related]

  • 13. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM, Gorechlad J, Larsen CP, Waller EK.
    Biol Blood Marrow Transplant; 2006 Dec 15; 12(12):1239-49. PubMed ID: 17162205
    [Abstract] [Full Text] [Related]

  • 14. Alloreactive CD4 T lymphocytes responsible for acute and chronic graft-versus-host disease are contained within the CD45RChigh but not the CD45RClow subset.
    Xystrakis E, Bernard I, Dejean AS, Alsaati T, Druet P, Saoudi A.
    Eur J Immunol; 2004 Feb 15; 34(2):408-17. PubMed ID: 14768045
    [Abstract] [Full Text] [Related]

  • 15. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD, Becker EE, LaBelle JL, Truitt RL.
    J Immunol; 1999 Dec 15; 163(12):6479-87. PubMed ID: 10586039
    [Abstract] [Full Text] [Related]

  • 16. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, Vaage JT, Rolstad B.
    Transplantation; 2008 Jan 15; 85(1):102-11. PubMed ID: 18192919
    [Abstract] [Full Text] [Related]

  • 17. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Jan 15; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 18. Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease.
    Badillo AT, Peranteau WH, Heaton TE, Quinn C, Flake AW.
    Br J Haematol; 2008 Apr 15; 141(2):224-34. PubMed ID: 18318768
    [Abstract] [Full Text] [Related]

  • 19. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
    Kaneda H, Adachi Y, Saito Y, Ikebukuro K, Machida H, Suzuki Y, Minamino K, Zhang Y, Iwasaki M, Nakano K, Koike Y, Wang J, Imamura H, Ikehara S.
    J Heart Lung Transplant; 2005 Sep 15; 24(9):1415-23. PubMed ID: 16143265
    [Abstract] [Full Text] [Related]

  • 20. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S, Kim JC, Whitaker-Menezes D, Murphy GF, Friedman TM, Korngold R.
    Biol Blood Marrow Transplant; 2004 Oct 15; 10(10):669-80. PubMed ID: 15389433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.